Patents by Inventor Minghua HU
Minghua HU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240079443Abstract: A light emitting plate, a wiring plate and a display device are provided. The light emitting plate includes light emitting units. Each light emitting unit includes a light emitting sub-unit including a connection line unit and a light emitting diode chip connected with the connection line unit. The connection line unit includes electrical contact pairs, and each electrical contact pairs includes a first electrode contact and a second electrode contact; in each connection line unit, the second electrode contacts are electrically connected with each other, the first electrode contacts are electrically connected with each other, and only one electrical contact pairs in each connection line unit is connected with the light emitting diode chip; in each connection line unit, at least two first electrode contacts are arranged adjacent to each other, and at least two first electrode contacts are arranged between at least two second electrode contacts.Type: ApplicationFiled: November 13, 2023Publication date: March 7, 2024Applicant: BOE TECHNOLOGY GROUP CO., LTD.Inventors: Ming YANG, Wei HAO, Qibing GU, Guofeng HU, Lingyun SHI, Minghua XUAN, Can ZHANG
-
Patent number: 11026988Abstract: The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprising Lycii fructus polysaccharide, Polygonati rhizoma polysaccharide, Caryophylli flos oil and Cinnamomi cortex oil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4+ and CD8+ cells in lymphocytes of the tumor stroma, increases body immune function, recovers normal immune surveillance function, decreases the expression rate of VEGF and TGF-? 1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.Type: GrantFiled: August 8, 2018Date of Patent: June 8, 2021Assignee: INFINITUS (CHINA) COMPANY LTD.Inventors: Fangli Ma, Yuanyuan Wang, Minghua Hu, Renhuai Cong, Lingyun Xiao, Chung Wah Ma
-
Patent number: 10967016Abstract: The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprising GANODERMA polysaccharide, MORINDAE OFFICINALIS RADIX polysaccharide, POLYGONATI RHIZOMA polysaccharide, ANGELICAE SINENSIS RADIX oil and MYRISTICAE SEMEN oil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4+ and CD8+ cells in lymphocytes of the tumor stroma, enhances body immune function, restores normal immune surveillance function, decreases VEGF and TGF-?1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.Type: GrantFiled: August 8, 2018Date of Patent: April 6, 2021Assignee: INFINITUS (CHINA) COMPANY LTD.Inventors: Yuanyuan Wang, Fangli Ma, Renhuai Cong, Minghua Hu, Chung Wah Ma
-
Patent number: 10968495Abstract: Provided is a strain CCFM8631 of Lactobacillus reuteri and use thereof. The strain CCFM8631 of Lactobacillus reuteri can significantly increase neurotransmitter 5-hydroxytryptamine level in peripheral blood, recover the hormone levels, for example testosterone and so on in peripheral blood of rat, normalize abnormal abundances of Blautia genus and Turicibacter genus, Oscillospira genus and Bifidobacterium genus in intestinal flora of rat affected by high-fat high-starch diet, show good tolerance to simulated gastrointestinal fluid and quickly colonize in intestinal, significantly improve pathological damages of tissues such as liver, duodenum and so on, and increase triglyceride and total cholesterol levels in serum and oral glucose tolerance of rat with metabolic syndrome caused by high-fat high-starch diet.Type: GrantFiled: August 23, 2018Date of Patent: April 6, 2021Assignee: INFINITUS (CHINA) COMPANY LTD.Inventors: Fangli Ma, Wei Chen, Gang Wang, Guangsu Zhu, Yuanyuan Wang, Lingyun Xiao, Minghua Hu, Hao Zhang, Jianxin Zhao, Chung Wah Ma
-
Patent number: 10967017Abstract: The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprising GANODERMA polysaccharide, GRIFOLA FRONDOSA polysaccharide, ANGELICAE SINENSIS RADIX oil and CINNAMOMI CORTEX oil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4+ and CD8+ cells in lymphocytes of the tumor stroma, increases body immune function, recovers normal immune surveillance function, decreases the expression rate of VEGF and TGF-? 1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.Type: GrantFiled: August 9, 2018Date of Patent: April 6, 2021Assignee: INFINITUS (CHINA) COMPANY LTD.Inventors: Minghua Hu, Fangli Ma, Yuanyuan Wang, Chung Wah Ma, Renhuai Cong, Lingyun Xiao
-
Publication number: 20210064917Abstract: The present invention discloses a method for measuring an airport flight waveform similarity by spectral clustering based on a trend distance. This method first transforms arrival and departure flight wave series of airports into trend series by using a time series trend symbolization method, and then measures the similarity of the arrival and departure flight waves of different airports by using spectral clustering based on a trend distance. The present invention realizes the purpose of scientific determination of the airport's transfer capacity and functional orientation from the demand level. Compared with those adopting empirical identification and evaluation indicator comparison, the airport classification method of the present invention is more reasonable and objective.Type: ApplicationFiled: August 27, 2020Publication date: March 4, 2021Inventors: Zheng ZHAO, Chencheng XU, Jiaming GE, Changcheng LI, Minghua HU
-
Patent number: 10744173Abstract: The present invention relates to the technical field of health-care product, and in particular relates to a traditional Chinese medicine composition having a function of regulating emotions, a process for preparing the same, and a product thereof. It was found that the composition of the present invention had effects of nourishing liver and kidney, regulating Yin and Yang, tonifying Qi and nourishing blood, regulating emotions, and protecting the function of autonomic nerve, and could improve pressure-induced anxiety and depression, inattention, poor spirit, dispirited, learning and memory capacity decline, etc. The invention has the advantages of specificity and remarkable effect, and it uses all natural medicinal and edible plants as raw materials, the combination of which is simple, safe and stable, and is suitable for long-term use.Type: GrantFiled: January 29, 2018Date of Patent: August 18, 2020Assignee: INFINITUS (CHINA) COMPANY LTD.Inventors: Lingyun Xiao, Renhuai Cong, Minghua Hu, Yuanyuan Wang, Fangli Ma, Chung Wah Ma
-
Publication number: 20190112675Abstract: Provided is a strain CCFM8631 of Lactobacillus reuteri and use thereof. The strain CCFM8631 of Lactobacillus reuteri can significantly increase neurotransmitter 5-hydroxytryptamine level in peripheral blood, recover the hormone levels, for example testosterone and so on in peripheral blood of rat, normalize abnormal abundances of Blautia genus and Turicibacter genus, Oscillospira genus and Bifidobacterium genus in intestinal flora of rat affected by high-fat high-starch diet, show good tolerance to simulated gastrointestinal fluid and quickly colonize in intestinal, significantly improve pathological damages of tissues such as liver, duodenum and so on, and increase triglyceride and total cholesterol levels in serum and oral glucose tolerance of rat with metabolic syndrome caused by high-fat high-starch diet.Type: ApplicationFiled: August 23, 2018Publication date: April 18, 2019Applicant: INFINITUS (CHINA) COMPANY LTD.Inventors: Fangli MA, Wei CHEN, Gang WANG, Guangsu ZHU, Yuanyuan WANG, Lingyun XIAO, Minghua HU, Hao ZHANG, Jianxin ZHAO, Chung Wah MA
-
Publication number: 20190112674Abstract: Provided is a strain CCFM8630 of Bifidobacterium adolescentis and use thereof. The strain CCFM8630 of Bifidobacterium adolescentis can significantly increase neurotransmitter 5-hydroxytryptamine level in peripheral blood of rat, recover the hormone levels, for example testosterone and so on in peripheral blood of rat, normalize abnormal abundances of Bifidobacterium genus, Blautia genus and Turicibacter genus in intestinal flora of rat affected by high-fat high-starch diet, show pretty good tolerance to simulated gastrointestinal fluid and quickly colonize in intestinal, significantly improve pathological damages of tissues such as liver, duodenum and so on, and increase triglyceride and total cholesterol levels in serum and oral glucose tolerance of rat with metabolic syndrome caused by high-fat high-starch diet.Type: ApplicationFiled: August 22, 2018Publication date: April 18, 2019Applicant: INFINITUS (CHINA) COMPANY LTD.Inventors: Yuanyuan WANG, Wei CHEN, Gang WANG, Guangsu ZHU, Fangli MA, Lingyun XIAO, Minghua HU, Hao ZHANG, Jianxin ZHAO, Chung Wah MA
-
Publication number: 20190070237Abstract: The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprising GANODERMA polysaccharide, GRIFOLA FRONDOSA polysaccharide, ANGELICAE SINENSIS RADIX oil and CINNAMOMI CORTEX oil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4+ and CD8+ cells in lymphocytes of the tumor stroma, increases body immune function, recovers normal immune surveillance function, decreases the expression rate of VEGF and TGF-? 1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.Type: ApplicationFiled: August 9, 2018Publication date: March 7, 2019Applicant: INFINITUS (CHINA) COMPANY LTD.Inventors: Minghua HU, Fangli MA, Yuanyuan WANG, Chung Wah MA, Renhuai CONG, Lingyun XIAO
-
Publication number: 20190070246Abstract: The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprising LYCII FRUCTUS polysaccharide, POLYGONATI RHIZOMA polysaccharide, CARYOPHYLLI FLOS oil and CINNAMOMI CORTEX oil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4+ and CD8+ cells in lymphocytes of the tumor stroma, increases body immune function, recovers normal immune surveillance function, decreases the expression rate of VEGF and TGF-? 1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.Type: ApplicationFiled: August 8, 2018Publication date: March 7, 2019Applicant: INFINITUS (CHINA) COMPANY LTD.Inventors: Fangli MA, Yuanyuan WANG, Minghua HU, Renhuai CONG, Lingyun XIAO, Chung Wah MA
-
Publication number: 20190070236Abstract: The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprising GANODERMA polysaccharide, MORINDAE OFFICINALIS RADIX polysaccharide, POLYGONATI RHIZOMA polysaccharide, ANGELICAE SINENSIS RADIX oil and MYRISTICAE SEMEN oil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4+ and CD8+ cells in lymphocytes of the tumor stroma, enhances body immune function, restores normal immune surveillance function, decreases VEGF and TGF-?1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.Type: ApplicationFiled: August 8, 2018Publication date: March 7, 2019Applicant: INFINITUS (CHINA) COMPANY LTD.Inventors: Yuanyuan WANG, Fangli MA, Renhuai CONG, Minghua HU, Chung Wah MA
-
Publication number: 20180369308Abstract: The present disclosure relates to the field of health care product and food technology, disclosing a Chinese herbal medicine composition having a function of relieving hypothyroidism, and preparation method and use thereof. The Chinese herbal medicine composition described in the present disclosure, in parts by weight, comprises: 10 to 100 parts of GINSENG RADIX ET RHIZOMA, 10 to 100 parts of LYCII FRUCTUS, and 6 to 60 parts of CINNAMOMI CORTEX. The Chinese herbal medicine composition described in the present disclosure adopts GINSENG RADIX ET RHIZOMA, LYCII FRUCTUS and CINNAMOMI CORTEX as starting materials, creates synergistic effects through rational combination. Experiments indicate that the Chinese herbal medicine composition described in the present disclosure can improve functions of the thyroid gland in rat hypothyroidism model, reduce serum VEGF level in the model, showing a function of relieving hypothyroidism and protecting the thyroid gland.Type: ApplicationFiled: June 22, 2018Publication date: December 27, 2018Applicant: INFINITUS (CHINA) COMPANY LTD.Inventors: Lingyun XIAO, Renhuai CONG, Minghua HU, Yuanyuan WANG, Fangli MA, Chung Wah MA
-
Publication number: 20180296618Abstract: The present invention relates to the technical field of health-care product, and in particular relates to a traditional Chinese medicine composition having a function of regulating emotions, a process for preparing the same, and a product thereof. It was found that the composition of the present invention had effects of nourishing liver and kidney, regulating Yin and Yang, tonifying Qi and nourishing blood, regulating emotions, and protecting the function of autonomic nerve, and could improve pressure-induced anxiety and depression, inattention, poor spirit, dispirited, learning and memory capacity decline, etc. The invention has the advantages of specificity and remarkable effect, and it uses all natural medicinal and edible plants as raw materials, the combination of which is simple, safe and stable, and is suitable for long-term use.Type: ApplicationFiled: January 29, 2018Publication date: October 18, 2018Applicant: Infinitus (China) Company Ltd.Inventors: Lingyun Xiao, Renhuai Cong, Minghua Hu, Yuanyuan Wang, Fangli Ma, Chung Wah Ma
-
Publication number: 20180236059Abstract: The present invention relates to the field of food or health care product, in particular a polysaccharide composition and use thereof. In the present invention, lentinan, pachymaran and tremellan are compounded. The resultant composition can significantly improve the survival rate and quality of life of mice infected by influenza virus, improve the pulmonary inflammatory lesion degree in mice infected by influenza virus, significantly improve levels of specific antibodies in serum of mice infected by influenza virus, significantly decrease the virus content in the lung of mice infected by influenza virus, as well as improve levels of cytokines IL-2 and IL-5 in the lung. In comparison with existing vaccines or single polysaccharides, the polysaccharide composition as provided in the present invention has more significant protective effects on mice infected by influenza virus.Type: ApplicationFiled: April 19, 2018Publication date: August 23, 2018Applicant: INFINITUS (CHINA) COMPANY LTD.Inventors: Minghua HU, Chung Wah MA, Fangli MA, Xiaolei GUO, Zhen LUO, Xiquan YIN
-
Publication number: 20170258887Abstract: The present invention relates to the field of food or health care product, in particular a polysaccharide composition and use thereof. In the present invention, lentinan, pachymaran and tremellan are compounded. The resultant composition can significantly improve the survival rate and quality of life of mice infected by influenza virus, improve the pulmonary inflammatory lesion degree in mice infected by influenza virus, significantly improve levels of specific antibodies in serum of mice infected by influenza virus, significantly decrease the virus content in the lung of mice infected by influenza virus, as well as improve levels of cytokines IL-2 and IL-5 in the lung. In comparison with existing vaccines or single polysaccharides, the polysaccharide composition as provided in the present invention has more significant protective effects on mice infected by influenza virus.Type: ApplicationFiled: June 30, 2016Publication date: September 14, 2017Applicant: INFINITUS (CHINA) COMPANY LTD.Inventors: Minghua HU, Chung Wah MA, Fangli MA, Xiaolei GUO, Zhen LUO, Xiquan YIN
-
Patent number: 9737477Abstract: The present invention discloses the use of a ginseng and tuber fleeceflower root complex polysaccharide in the preparation of health-care food having anti-aging efficacies, the complex polysaccharide is ginseng and tuber fleeceflower root complex polysaccharide, with ginseng and/or tuber fleeceflower root as raw material, the complex polysaccharide is obtained by water extraction, concentration and alcohol precipitation processes. The complex polysaccharide in the present invention, as proved by Caenorhabditis elegans model experiment, is able to prolong the average life span of wild-type, oxidation stress model and protein aggregation toxin model effectively, the effect pathway is closely related to improving anti-oxidation ability in C. elegans, inhibiting toxic aggregation protein stress, enhancing the activity of heat-block protein and regulating the crucial node of insulin signalling pathway, which demonstrates that it has good effect of delaying aging and preventing aging-related diseases.Type: GrantFiled: February 6, 2015Date of Patent: August 22, 2017Assignee: Infinitus (China) Company Ltd.Inventors: Minghua Hu, Ming Liang, Haifeng Li, Fangli Ma
-
Patent number: 9662349Abstract: The present invention discloses a Lucid Ganoderma, Lycium barbarum and Polygonatum sibiricum complex polysaccharide having efficacy for regulating tumor microenvironment, whose active components are complexed by Lucid Ganoderma polysaccharide, Lycium barbarum polysaccharide and Polygonatum sibiricum polysaccharide, the mass proportion ratio of each component is Lucid Ganoderma polysaccharide 10-250, Lycium barbarum polysaccharide 1-50, Polygonatum sibiricum polysaccharide 2-10. The Lucid Ganoderma, Lycium barbarum and Polygonatum sibiricum complex polysaccharide is high in purity and activity, has an efficacy for regulating tumor microenvironment. The present invention also discloses the preparation method of aforesaid Lucid Ganoderma, Lycium barbarum and Polygonatum sibiricum complex polysaccharide, said method is simple, stable and efficient in the process, suitable for industrial production and economic.Type: GrantFiled: February 6, 2015Date of Patent: May 30, 2017Assignee: Infinitus (China) Company Ltd.Inventors: Minghua Hu, Fangli Ma, Peipei Wang, Ming Liang
-
Publication number: 20160045428Abstract: The present invention discloses the use of a ginseng and tuber fleeceflower root complex polysaccharide in the preparation of health-care food having anti-aging efficacies, the complex polysaccharide is ginseng and tuber fleeceflower root complex polysaccharide, with ginseng and/or tuber fleeceflower root as raw material, the complex polysaccharide is obtained by water extraction, concentration and alcohol precipitation processes. The complex polysaccharide in the present invention, as proved by Caenorhabditis elegans model experiment, is able to prolong the average life span of wild-type, oxidation stress model and protein aggregation toxin model effectively, the effect pathway is closely related to improving anti-oxidation ability in C. elegans, inhibiting toxic aggregation protein stress, enhancing the activity of heat-block protein and regulating the crucial node of insulin signalling pathway, which demonstrates that it has good effect of delaying aging and preventing aging-related diseases.Type: ApplicationFiled: February 6, 2015Publication date: February 18, 2016Applicant: Infinitus (China) Company Ltd.Inventors: Minghua HU, Ming LIANG, Haifeng LI, Fangli MA
-
Publication number: 20150366896Abstract: The present invention discloses a Lucid Ganoderma, Lycium barbarum and Polygonatum sibiricum complex polysaccharide having efficacy for regulating tumor microenvironment, whose active components are complexed by Lucid Ganoderma polysaccharide, Lycium barbarum polysaccharide and Polygonatum sibiricum polysaccharide, the mass proportion ratio of each component is Lucid Ganoderma polysaccharide 10-250, Lycium barbarum polysaccharide 1-50, Polygonatum sibiricum polysaccharide 2-10. The Lucid Ganoderma, Lycium barbarum and Polygonatum sibiricum complex polysaccharide is high in purity and activity, has an efficacy for regulating tumor microenvironment. The present invention also discloses the preparation method of aforesaid Lucid Ganoderma, Lycium barbarum and Polygonatum sibiricum complex polysaccharide, said method is simple, stable and efficient in the process, suitable for industrial production and economic.Type: ApplicationFiled: February 6, 2015Publication date: December 24, 2015Applicant: Infinitus (China) Company Ltd.Inventors: Minghua HU, Fangli MA, Peipei WANG, Ming LIANG